Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1h)- one and derivatives thereof
06/07/2012US20120142636 Novel glucokinase activators and methods of using same
06/07/2012US20120142635 Oxazolidinone-quinolone hybrid antibiotics
06/07/2012US20120142634 Method of Treating Cancer with a Combination of a Proteasome Inhibitor and Salubrinal
06/07/2012US20120142633 Methylpyrrolopyridinecarboxamides
06/07/2012US20120142632 Diagnostic and prognostic assay
06/07/2012US20120142631 Medicinal antidiaper rash cream incorporating a biopolymer and a process to make it
06/07/2012US20120142630 Process for purifying guar
06/07/2012US20120142629 Pharmaceutical composition for relieving pain
06/07/2012US20120142628 Methods for treating crepitus
06/07/2012US20120142627 Monophosphate prodrugs of dapd and analogs thereof
06/07/2012US20120142626 Compounds
06/07/2012US20120142625 Substituted Purine And 7-Deazapurine Compounds
06/07/2012US20120142624 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy
06/07/2012US20120142623 Compositions And Methods For Predicting Inhibitors Of Protein Targets
06/07/2012US20120142622 Stambomycin and derivatives, their production and their use as drugs
06/07/2012US20120142621 Purified Ethyl Ester Sophorolipid for the Treatment of Sepsis
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142619 Medicinal carbohydrates for treatment of respiratory conditions
06/07/2012US20120142618 Ketogenic saccharides
06/07/2012US20120142617 Antiviral therapeutic agents
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142590 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120142581 Polymer Formulations for Delivery of Bioactive Materials
06/07/2012US20120142580 Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120141615 Method for suppressing and relieving itching and inflammation
06/07/2012US20120141614 Protection Against Sunburn and Skin Problems With Orally-Ingested High-Dosage Zeaxanthin
06/07/2012US20120141611 Methods and compositions using ergothioneine to treat a variety of health related factors
06/07/2012US20120141608 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as anthrax, virus or radiation and use in combination with dhea for the treatment of viruses
06/07/2012US20120141606 Sigma ligands for the prevention or treatment of pain induced by chemotherapy
06/07/2012US20120141605 Pyrazoloanthrone and derivatives thereof for treatment of cancer and excess androgen states
06/07/2012US20120141604 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers
06/07/2012US20120141603 Methods and compositions for lung cancer prognosis
06/07/2012US20120141594 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy, and anti-cancer activity and methods of use
06/07/2012US20120141592 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
06/07/2012US20120141591 Drug Delivery Nanocarriers Targeted by Landscape Phage
06/07/2012US20120141590 Technology for the Preparation of Microparticles
06/07/2012US20120141589 Particles for drug delivery and other applications
06/07/2012US20120141587 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
06/07/2012US20120141586 Thrombin receptor antagonist and clopidogrel fixed dose tablet
06/07/2012US20120141583 Alcohol resistant dosage forms
06/07/2012US20120141578 Compositions and methods relating to proliferative diseases
06/07/2012US20120141577 Linear expression cassette vaccines
06/07/2012US20120141576 Treatment of Dermatologic Skin Disorders
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141569 Wipe Coated with a Botanical Composition having Antimicrobial Properties
06/07/2012US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
06/07/2012US20120141563 Pharmaceutical composition including a dha ester to be administered parenterally
06/07/2012US20120141561 Nanoparticulate candesartan cilexitil compositions, process for the preparation thereof and pharmaceutical compositions containing them
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141557 Highly-mineralized osteogenic sponge compositions and uses thereof
06/07/2012US20120141554 Delayed release formulation for reducing the frequency of urination and method of use thereof
06/07/2012US20120141553 Biocompatible polymer fibres for neuroimplants
06/07/2012US20120141550 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
06/07/2012US20120141549 Oligonucleotides targeting asthma inflammation processes
06/07/2012US20120141548 Novel formulation of meloxicam
06/07/2012US20120141545 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141544 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141543 Carbon Nanotube Based Nanocomposites
06/07/2012US20120141542 Method of using punicic acid to enhance immune response and prevent metabolic disorders
06/07/2012US20120141541 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
06/07/2012US20120141539 Methods for modulating toll-like receptor mediated activation of cells of the innate system by modulating xbp-1 activity
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141531 Composition comprising oil drops
06/07/2012US20120141524 Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof
06/07/2012US20120141513 Deuterated fingolimod
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141498 Use of pkc isozymes for diagnosis and treatment of neuroblastoma
06/07/2012US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections
06/07/2012US20120141488 Novel g protein coupled receptor protein and use thereof
06/07/2012US20120141483 Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives
06/07/2012US20120141479 Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors
06/07/2012US20120141478 Compositions and methods for delivering anti-activated ras antibodies
06/07/2012US20120141475 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141474 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141472 Methods of scoring gene copy number in a biological sample using in situ hybridization
06/07/2012US20120141471 Methods of Inhibiting Metastasis from Cancer
06/07/2012US20120141468 Maintenance of platelet inhibition during antiplatelet therapy
06/07/2012US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
06/07/2012US20120141461 Compositions and methods for diagnosing and treating fibrotic disorders
06/07/2012US20120141459 Molecular targets for als and related disorders
06/07/2012US20120141456 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
06/07/2012US20120141454 Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
06/07/2012US20120141448 Method for increasing muscle mass and strength
06/07/2012US20120141447 Nutritional supplement
06/07/2012US20120141446 Oral Nutritional Supplement Delivery System
06/07/2012US20120141442 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
06/07/2012US20120141435 Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis
06/07/2012US20120141430 Tissue Regeneration Membrane
06/07/2012US20120141424 Materials and Methods for the Treatment of Hypertension
06/07/2012US20120141412 Methods of treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
06/07/2012US20120141409 Multi-valent adjuvant display
06/07/2012US20120141408 High Water Content Ophthalmic Devices
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 7860